Core Insights - The eighth China International Import Expo (CIIE) was held in Shanghai from November 5 to 10, where JD Health deepened partnerships with leading global pharmaceutical companies [1] - JD Health is actively upgrading its health service ecosystem, focusing on patient-centered care and exploring diverse collaboration opportunities with pharmaceutical companies [1] Strategic Collaborations - JD Health and Eli Lilly held closed-door meetings to discuss diabetes management and a 2026 cooperation plan, focusing on enhancing professional education for healthcare providers [2] - JD Health is a key member of Novo Nordisk's "Health Ecosystem Alliance," collaborating on a comprehensive service model for obesity and diabetes management [4] - Bayer and JD Health signed a memorandum to launch a "Comprehensive Women's Health Literacy Improvement Program," integrating medical resources and digital capabilities [6] - Kasey Pharmaceuticals partnered with JD Health to enhance accessibility and adherence for respiratory disease medications through various collaborative efforts [8] - Sanofi and JD Health established a diabetes management center, focusing on integrated health services for type 1 diabetes patients [10] Focus on Specific Health Areas - JD Health and Ogalon are creating a comprehensive hair health management ecosystem, enhancing patient experiences in hair loss treatment [10] - A collaboration with Novartis aims to address the needs of over 10 million patients with chronic spontaneous urticaria (CSU) [12] - JD Health and AstraZeneca are enhancing home care solutions for chronic disease management, focusing on patient education and accessibility [14] - A partnership with Pfizer aims to improve treatment experiences for alopecia patients through an integrated service system [15] Technology and Innovation - JD Health participated in a roundtable forum hosted by Bayer, discussing the role of AI in self-health management and improving health consumer experiences [15] - The company is leveraging its "super pharmaceutical supply chain" and digital capabilities to enhance collaboration with multinational pharmaceutical companies [15]